BACKGROUND: Dendritic cells (DCs) are antigen presenting cells capable of inducing specific immune responses against microbial infections, transplant antigens, or tumors. Interestingly, microenvironment conditions such as those present in tumor settings might induce a DC phenotype that is poorly immunogenic and with the capability of promoting angiogenesis. We hypothesize that this plasticity may be caused not only by the action of specific cytokines or growth factors but also by the properties of the surfaces with which they interact, such as extracellular matrix (ECM) components. RESULTS: Herewith we studied the effect of different surfaces and soluble factors on the biology of DCs. To accomplish this, we cultured murine myeloid(m) DCs on surfaces coated with fibronectin, collagen I, gelatin, and Matrigel using poly-D-lysine and polystyrene as non-biological surfaces. Further, we cultured these cells in the presence of regular DC medium (RPMI 10% FBS) or commercially available endothelial medium (EGM-2). We determined that mDCs could be kept in culture up to 3 weeks in these conditions, but only in the presence of GM-CSF. We were able to determine that long-term DC cultures produce an array of angiogenic factors, and that some of these cultures still retain the capability to induce T cell responses. CONCLUSIONS: Altogether these data indicate that in order to design DC-based vaccines or treatments focused on changing the phenotype of DCs associated with diseases such as cancer or atherosclerosis, it becomes necessary to fully investigate the microenvironment in which these cells are present or will be delivered.
BACKGROUND: Dendritic cells (DCs) are antigen presenting cells capable of inducing specific immune responses against microbial infections, transplant antigens, or tumors. Interestingly, microenvironment conditions such as those present in tumor settings might induce a DC phenotype that is poorly immunogenic and with the capability of promoting angiogenesis. We hypothesize that this plasticity may be caused not only by the action of specific cytokines or growth factors but also by the properties of the surfaces with which they interact, such as extracellular matrix (ECM) components. RESULTS: Herewith we studied the effect of different surfaces and soluble factors on the biology of DCs. To accomplish this, we cultured murine myeloid(m) DCs on surfaces coated with fibronectin, collagen I, gelatin, and Matrigel using poly-D-lysine and polystyrene as non-biological surfaces. Further, we cultured these cells in the presence of regular DC medium (RPMI 10% FBS) or commercially available endothelial medium (EGM-2). We determined that mDCs could be kept in culture up to 3 weeks in these conditions, but only in the presence of GM-CSF. We were able to determine that long-term DC cultures produce an array of angiogenic factors, and that some of these cultures still retain the capability to induce T cell responses. CONCLUSIONS: Altogether these data indicate that in order to design DC-based vaccines or treatments focused on changing the phenotype of DCs associated with diseases such as cancer or atherosclerosis, it becomes necessary to fully investigate the microenvironment in which these cells are present or will be delivered.
Authors: Douglas A Carlow; Klaus Gossens; Silvia Naus; Krystle M Veerman; Wooseok Seo; Hermann J Ziltener Journal: Immunol Rev Date: 2009-07 Impact factor: 12.988
Authors: Juan R Cubillos-Ruiz; Xavier Engle; Uciane K Scarlett; Diana Martinez; Amorette Barber; Raul Elgueta; Li Wang; Yolanda Nesbeth; Yvon Durant; Andrew T Gewirtz; Charles L Sentman; Ross Kedl; Jose R Conejo-Garcia Journal: J Clin Invest Date: 2009-07-13 Impact factor: 14.808
Authors: Eduardo Huarte; Juan R Cubillos-Ruiz; Yolanda C Nesbeth; Uciane K Scarlett; Diana G Martinez; Ronald J Buckanovich; Fabian Benencia; Radu V Stan; Tibor Keler; Pablo Sarobe; Charles L Sentman; Jose R Conejo-Garcia Journal: Cancer Res Date: 2008-09-03 Impact factor: 12.701
Authors: Yuri V Bobryshev; Dinh Tran; Murray C Killingsworth; Michael Buckland; Reginald V N Lord Journal: J Gastrointest Surg Date: 2008-11-18 Impact factor: 3.452
Authors: Matthias Schweizerhof; Sebastian Stösser; Martina Kurejova; Christian Njoo; Vijayan Gangadharan; Nitin Agarwal; Martin Schmelz; Kiran Kumar Bali; Christoph W Michalski; Stefan Brugger; Anthony Dickenson; Donald A Simone; Rohini Kuner Journal: Nat Med Date: 2009-06-07 Impact factor: 53.440
Authors: Nils Scheib; Jessica Tiemann; Christian Becker; Hans Christian Probst; Verena Katharina Raker; Kerstin Steinbrink Journal: Front Immunol Date: 2022-06-28 Impact factor: 8.786
Authors: Elisabet Aguilar; Julio Rodriguez Bagó; Carol Soler-Botija; Maria Alieva; Maria Angeles Rigola; Carme Fuster; Olaia F Vila; Nuria Rubio; Jeronimo Blanco Journal: Stem Cells Dev Date: 2014-08-13 Impact factor: 3.272
Authors: Adva Cohen-Fredarow; Ari Tadmor; Tal Raz; Naama Meterani; Yoseph Addadi; Nava Nevo; Inna Solomonov; Irit Sagi; Gil Mor; Michal Neeman; Nava Dekel Journal: Mol Endocrinol Date: 2014-05-13
Authors: Arun H S Kumar; Kenneth Martin; Elizebeth C Turner; Chirlei K Buneker; Karim Dorgham; Philippe Deterre; Noel M Caplice Journal: PLoS One Date: 2013-02-21 Impact factor: 3.240